Literature DB >> 1428566

Long-term drift and timolol therapy: possible role for pulsed therapy.

M Batterbury1, S P Harding, D Wong.   

Abstract

Eyes treated with a topical betablocker may exhibit the phenomenon of longterm drift, leading to loss of intraocular pressure control. It has been suggested that discontinuation of the betablocker may restore sensitivity to betablocker therapy, and that this phenomenon might be enhanced by the administration of an adrenergic agonist during this holiday period. This study was set up to examine further this hypothesis. Nine patients with ocular hypertension receiving treatment with timolol were entered into the study. Timolol was discontinued then re-started after four weeks of treatment with dipivefrin. This treatment cycle was repeated after a further four weeks. IOP was measured every two weeks. Re-introduction of timolol was associated with a significant lowering of IOP at two weeks (3.2 mmHg in the first cycle, p < 0.01, 3.4 mmHg in the second cycle, p < 0.01). Discontinuation of timolol and treatment with dipivefrin was not associated with a significant change in IOP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428566     DOI: 10.1007/bf00917984

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  16 in total

1.  Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma.

Authors:  S A Gandolfi
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-02       Impact factor: 4.799

Review 2.  Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model.

Authors:  D R Sibley; R J Lefkowitz
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

3.  A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics.

Authors:  M E Yablonski; T J Zimmerman; S R Waltman; B Becker
Journal:  Exp Eye Res       Date:  1978-08       Impact factor: 3.467

4.  Double-masked three-period crossover investigation of timolol in control of raised intraocular pressure.

Authors:  S H Campbell; M Hickey-Dwyer; S P Harding
Journal:  Eye (Lond)       Date:  1993       Impact factor: 3.775

5.  The mechanism of timolol in lowering intraocular pressure. In the normal eye.

Authors:  R L Coakes; R F Brubaker
Journal:  Arch Ophthalmol       Date:  1978-11

6.  Timolol and epinephrine: a clinical study of ocular interactions.

Authors:  I Goldberg; F S Ashburn; P F Palmberg; M A Kass; B Becker
Journal:  Arch Ophthalmol       Date:  1980-03

7.  Timolol and epinephrine in primary open angle glaucoma. Transient additive effect.

Authors:  J V Thomas; D L Epstein
Journal:  Arch Ophthalmol       Date:  1981-01

8.  Long-term drift and continued efficacy after multiyear timolol therapy.

Authors:  R F Steinert; J V Thomas; W P Boger
Journal:  Arch Ophthalmol       Date:  1981-01

9.  Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry.

Authors:  D J Townsend; R F Brubaker
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-03       Impact factor: 4.799

10.  Safety and effectiveness of concomitant administration of dipivefrin and timolol maleate.

Authors:  E U Keates; R A Stone
Journal:  Am J Ophthalmol       Date:  1981-02       Impact factor: 5.258

View more
  1 in total

1.  A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients.

Authors:  Gianluca Manni; Marco Centofanti; Mariacristina Parravano; Francesco Oddone; Massimo G Bucci
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.